Bryan Cave Combines with Berwin Leighton Paisner to Form Bryan Cave Leighton Paisner LLP Learn More

gradient
gradient

Andrew Hart is a corporate lawyer practicing in M&A and securities law.

He advises on domestic and cross-border transactional matters, including mergers and acquisitions of public (listed) and private companies, joint ventures, business and asset acquisitions, and issues of equity and debt capital to institutional and non-institutional investors. Andrew works closely with a number of the firm's US clients in connection with their international transactions and on-going EU operations.

Andrew is dual-qualified lawyer in England and Wales, and in Western Australia where he spent two years at one of the big six Australian law firms in 2011/2012.

Mr. Hart is recognised in The Legal 500 2017 for Corporate M&A – mid-market and described as ‘smart, pragmatic, calm, methodical and funny’.

Professional Affiliations

    • Associate (ACSI) member of the Chartered Institute for Securities and Investments in London.
Read More

Representative Experience

  • Wireless Telecom Group (NYSE: WTT): acting for WTT (a leader in advanced wireless communications solutions) in connection with the acquisition of UK company, CommAgility Ltd.
  • Terex Corporation (NYSE: TEX): disposal by Terex of manufacturing business (producing backhoe loaders, site dumpers and compaction rollers) based in Coventry, England to Groupe Mecalac S.A.
  • Sovcomflot Group: acting for SCF Group (Russia’s largest shipping company) in connection with the acquisition of 9 tankers from Primorsk International Shipping Ltd for an aggregate consideration of US$215m.
  • Monsanto Company (NYSE: MON): assisting with English law aspects of acquisition of WeatherMe OÜ (dba VitalFields).
  • Esco Technologies Inc (NYSE:ESE): the acquisition of the UK and Polish operations of the Plastique group of companies (which will become part ESCO's Thermoform Engineered Quality LLC (TEQ) operating subsidiary).
  • Enterprise-Rent-A-Car: various UK corporate acquisitions.
  • Ethypharm SA: acquisition of various UK and Swiss entities involved in the manufacture and distribution of off-patent prescription only medicines to UK retail and the UK National Health Service.
  • Futures Industry Association (a Washington-based not for profit whose members include major financial institutions active in commodities and futures markets): designing and implementing a merger with its allied associations in Europe and Asia in order to form one association to represent the global derivatives industry.
  • eClinicalWorks, LLC (a leader in healthcare IT solutions):  assisting in respect of all aspects of expansion into the EU and contractual arrangements with Specsavers (who will utilise eClinicalWorks’ international private cloud).
  • Extract Resources Limited (owner of the Husab Uranium Project in Namibia): $2.2 billion recommended unconditional cash offer by Taurus Mineral Limited, an entity owned by Chinese state-owned CGNPC Uranium Resources Co. and the China-Africa Development Fund.
  • Autogrill S.p.A. (a company listed on the Borsa Italia): £193m compulsory takeover of LSE listed Alpha Airports Group.
  • Edward D. Jones & Co. L.P.: disposal of UK regulated subsidiary, Edward Jones Limited to Towry Law Finance Company Limited for an undisclosed consideration.
  • U.S. family private equity fund: (i) the acquisition of Dataforce Interact Limited from AIM listed Twenty PLC and (ii) on the acquisition of EMR Group (a provider of outsourcing services with a focus on offering “back-office” and claims handling services to the insurance industry) plus post-acquisition consolidation into a simplified corporate structure.
  • Private investor group: acquisition of Aman Resorts, a leading international luxury hotel group, from DLF Global Hospitality Limited, a subsidiary of listed Indian property developer DLF Limited.
  • Victor Technologies Inc.: acquisition of Gas-Arc Group Ltd, a privately held manufacturer of gas control equipment based in the UK, for approximately $40 million.
  • ASX listed Tox Free Solutions Limited: A$27m institutional placement.